BEVERLY HILLS, CA / ACCESS Newswire / July 18, 2025 / World-renowned spinal neurosurgeon and motion preservation expert Dr.

Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, ...

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United ...

Spine tech developer Highridge Medical said it is commencing production "imminently" to launch the product later this year.

Highridge Medical licensed the U.S. rights for the activL lumbar artificial disc implant, according to a July 8 news release. The company is “imminently” beginning production for the launch of its ...

Explore the $0.6Bn artificial disc replacement market projected to reach $1.3Bn by 2030. Discover growth drivers, challenges, major players, and emerging trends in spinal care innovation.

Thus, given the lack of information about the long term clinical impact of artificial cervical disc replacement, whether or not the technology ultimately improves net health outcomes is not known.

The California Technology Assessment Forum reviews the scientific literature on the safety and efficacy of artificial spinal disc replacement for the treatment of neck pain caused by cervical ...

Today, we are doing a cervical artificial disc replacement. This is a procedure that is done to replace the cushions in the neck with artificial ones.

According to GlobalData’s medical device pipeline database, of the 12 Cervical Total Disc Replacement Systems devices, 7 products are in the early stages of development, and the remaining 3 are in the ...